19th Conference of the APASL - Invitation to Industrial-Supported Satellite Symposia
Greetings from the 19th Conference of the APASL, thank you very much for registering for the conference, we would like to extend our warmest invitation to invite you to attend the following Industrial-Supported Satellite Symposia
| 13 February, Friday |
| Bukwang |
11:45-13:15 |
Meeting Room 601 |
The latest Discoveries of Clevudine: New agent and New concept for the treatment of HBV More... |
| Roche Diagnostics |
11:45-12:45 |
Meeting Room 608 |
New Approaches for Monitoring Therapy for Chronic Hepatitis B
More... |
| 14 February, Saturday |
| Novartis Pharma AG |
08:45-10:15 |
Hall 5A |
Optimizing Treatment Outcomes in CHB:Case Discussions With Leading Experts. More... |
| GlaxoSmithKline |
12:30-14:00 |
Hall 5A |
Predicting Response to Treatment in Chronic Hepatitis B More... |
| Schering-Plough |
17:00-18:30 |
Convention Hall A |
Optimizing Treatment Strategies for Patients with Chronic Hepatitis B & C: Current and Future Therapies More... |
| Abbott Molecular |
17:00-18:30 |
Meeting Room 608 |
Setting a new standard in hepatitis management More... |
| 15 February, Sunday |
| Roche |
08:00-10:00 |
Hall 5A |
Striving for clinical cure Achieving success with PEGASYS® in chronic hepatitis More... |
| Bristol-Myers Squibb |
12:30-14:00 |
Hall 5A |
Reversing CHB-Induced Liver Damage: Impact of Potent Antivirals with a High Genetic Barrier to Resistance More... |
| Merz Pharmaceutical GmbH |
17:00-18:30 |
Convention Hall A |
Hepatic Encephalopathy - an International Perspective? More... |
| SciClone |
17:00-18:00 |
Meeting Room 608 |
New Therapies in Liver Cancer and Hepatitis More... |
| Bayer Schering Pharma |
18:30-20:00 |
Hall 5A |
State of the Art in HCC Management: From Diagnosis to Treatment More... |